BRIEF-North China Pharmaceutical Says Unit's Anti-Monopoly Case Recinded
BRIEF-North China Pharmaceutical Says Unit's Anti-Monopoly Case Recinded
簡報-華北製藥稱單位反壟斷案重新審理
Nov 8 (Reuters) - North China Pharmaceutical Co LTd
路透11月8日電-華北製藥有限公司
600812.SS :
600812.SS:
* SAYS UNIT'S ANTI-MONOPOLY CASE HAS BEEN RECINDED BY U.S. COURT IN NEW YORK
*表示單位的反壟斷案件已被紐約美國法院重新審理
Source text Further company coverage: 600812.SS
源文本進一步公司報道:600812.SS
(Reporting by Hong Kong newsroom)
(香港新聞編輯部報道)
((meg.shen@thomsonreuters.com; 852-39525805;))
(meg.shen@thomsonreurs.com;852-39525805;)